Evidence map›Paper›PMID 36101332›Full record

ArticleBiology2022

Improving the Accuracy of Diagnosis for Multiple-System Atrophy Using Deep Learning-Based Method.

Yasuhiro Kanatani, Yoko Sato, Shota Nemoto, Manabu Ichikawa, Osamu Onodera

Abstract read
In one paragraph

Article in Biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Fluid biomarkers in atypical Parkinsonism: current state and future perspectives.Journal of neural transmission (Vienna, Austria : 1996) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yasuhiro KanataniDepartment of Clinical Pharmacology, Tokai University School of Medicine, 143 Shimokasuya, Isehara City 259-1193, Japan.ORCID 0000-0001-5790-4084
Yoko SatoDivision of Clinical Biostatistics, Shizuoka Graduate University of Public Health, 4-27-1 Kitaando Aoi-ku, Shizuoka City 420-0881, Japan.ORCID 0000-0001-8123-5191
Shota NemotoIndustrial & Digital Business Unit, Hitachi, Ltd., 1-5-2 Sotokanda, Chiyoda-ku, Tokyo 101-0021, Japan.
Manabu IchikawaDepartment of Planning, Architecture and Environmental Systems, Shibaura Institute of Technology, 307 Fukasaku, Minuma-ku, Saitama City 337-8570, Japan.ORCID 0000-0002-5943-516X
Osamu OnoderaDepartment of Neurology, Brain Research Institute, Niigata University, 1-757 Asahimachidori, Chuo-ku, Niigata City 951-8585, Japan.

Funding

Ministry of Health Labour and Welfare 20FC1041
6 · The paper itself

Abstract

Multiple-system atrophy (MSA) is primarily an autonomic disorder with parkinsonism or cerebellar ataxia. Clinical diagnosis of MSA at an early stage is challenging because the symptoms change over the course of the disease. Recently, various artificial intelligence-based programs have been developed to improve the diagnostic accuracy of neurodegenerative diseases, but most are limited to the evaluation of diagnostic imaging. In this study, we examined the validity of diagnosis of MSA using a pointwise linear model (deep learning-based method). The goal of the study was to identify features associated with disease differentiation that were found to be important in deep learning. A total of 3377 registered MSA cases from FY2004 to FY2008 were used to train the model. The diagnostic probabilities of SND (striatonigral degeneration), SDS (Shy-Drager syndrome), and OPCA (olivopontocerebellar atrophy) were estimated to be 0.852 ± 0.107, 0.650 ± 0.235, and 0.858 ± 0.270, respectively. In the pointwise linear model used to identify and visualize features involved in individual subtypes, autonomic dysfunction was found to be a more prominent component of SDS compared to SND and OPCA. Similarly, respiratory failure was identified as a characteristic of SDS, dysphagia was identified as a characteristic of SND, and brain-stem atrophy was identified as a characteristic of OPCA.

Indexed as

artificial intelligencemultiple-system atrophypointwise linear model

Identifiers

PMID36101332
PMCPMC9312043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.